Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 97 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $73,537 | +12.8% | 13,493 | +40.6% | 0.00% | – |
Q2 2023 | $65,164 | -63.4% | 9,597 | -73.0% | 0.00% | – |
Q1 2023 | $177,875 | +6.0% | 35,504 | +3.2% | 0.00% | – |
Q4 2022 | $167,852 | -100.0% | 34,396 | -11.8% | 0.00% | -100.0% |
Q3 2022 | $562,539,000 | +365.9% | 39,011 | +388.9% | 0.00% | – |
Q2 2022 | $120,737,000 | +247.1% | 7,980 | +172.5% | 0.00% | – |
Q1 2022 | $34,785,000 | -76.4% | 2,928 | -67.8% | 0.00% | – |
Q4 2021 | $147,511,000 | -19.9% | 9,100 | +41.1% | 0.00% | – |
Q3 2021 | $184,054,000 | +256.4% | 6,449 | +322.1% | 0.00% | – |
Q2 2021 | $51,646,000 | -83.4% | 1,528 | -85.1% | 0.00% | – |
Q1 2021 | $310,414,000 | -90.8% | 10,265 | -84.9% | 0.00% | -100.0% |
Q4 2020 | $3,361,977,000 | +1142.4% | 67,905 | +863.3% | 0.01% | – |
Q3 2020 | $270,611,000 | +193.1% | 7,049 | +229.9% | 0.00% | – |
Q2 2020 | $92,318,000 | -65.8% | 2,137 | -79.3% | 0.00% | -100.0% |
Q1 2020 | $269,744,000 | +214.6% | 10,335 | +276.6% | 0.00% | – |
Q4 2019 | $85,750,000 | +17.2% | 2,744 | -2.3% | 0.00% | – |
Q3 2019 | $73,176,000 | +274.2% | 2,808 | +228.4% | 0.00% | – |
Q2 2019 | $19,554,000 | -48.4% | 855 | -40.9% | 0.00% | – |
Q1 2019 | $37,926,000 | – | 1,447 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |